Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Molecular detection of SARS‐CoV‐2 strains and differentiation of Delta variant strains.
Publication Type: Academic Journal
Source(s): Transboundary & Emerging Diseases. Sep2022, Vol. 69 Issue 5, p2879-2889. 11p.
Abstract: The Delta variant of SARS‐CoV‐2 has now become the predominant strain in the global COVID‐19 pandemic. Strain coverage of some detection assays developed during the early pandemic stages has declined due to periodic mutations in the viral genome. We ha...
Efficient Framework for Detection of COVID-19 Omicron and Delta Variants Based on Two Intelligent Phases of CNN Models.
Publication Type: Academic Journal
Source(s): Computational & Mathematical Methods in Medicine. 4/21/2022, p1-10. 10p.
Abstract: Introduction. While the COVID-19 pandemic was waning in most parts of the world, a new wave of COVID-19 Omicron and Delta variants in Central Asia and the Middle East caused a devastating crisis and collapse of health-care systems. As the diagnostic me...
SARS-CoV-2 variants and associated cases during four epidemic waves in Sinaloa, Mexico.
Publication Type: Academic Journal
Source(s): TIP Revista Especializada en Ciencias Químico-Biológicas. 2022, Vol. 25, p1-15. 15p.
Abstract: La pandemia de COVID-19 es un problema de salud pública que ha revelado las deficiencias y los retos presentes en el funcionamiento de los sistemas hospitalarios del mundo. En México, hasta el momento de finalizar esta recopilación, se han manifestado ...
COVID-19 Pandemic: Critical Actions Needed.
Publication Type: Academic Journal
Source(s): Annals of Abbasi Shaheed Hospital & Karachi Medical & Dental College. Dec2021, Vol. 26 Issue 4, p178-179. 2p.
Covid case rates up in mainland China and Hong Kong.
Publication Type: News
Source(s): BOFIT Weekly. 3/11/2022, Issue 10, p1-1. 1p. 1 Color Photograph.
Abstract: China has not approved the mRNA vaccines used in the West, preferring to stay with more traditional inactivated virus vaccines manufactured in China. Hong Kong residents also have access to the Pfizer-BioNTech mRNA vaccine, but the overall vaccination ...
Evaluation of the MAScIR SARS-CoV-2 M Kit 2.0 on the SARS-CoV-2 Infection.
Publication Type: Academic Journal
Source(s): Advances in Virology. 2/7/2023, p1-13. 13p.
Abstract: SARS-CoV-2 is a major public health problem worldwide. Since its emergence, several diagnostic kits have been developed to ensure rapid patient management. The aim of our study is to check the performance of the new Moroccan SARS-CoV-2 detection kit: M...
Molecular detection of SARS‐CoV‐2 and differentiation of Omicron and Delta variant strains.
Publication Type: Academic Journal
Source(s): Transboundary & Emerging Diseases. Sep2022, Vol. 69 Issue 5, pe1618-e1631. 14p.
Abstract: The SARS‐CoV‐2 virus is the causative agent of COVID‐19 and has undergone continuous mutations throughout the pandemic. The more transmissible Omicron variant has quickly spread and is replacing the Delta variant as the most prevalent strain globally, ...
Circulating Dynamics of SARS-CoV-2 Variants between April 2021 and February 2022 in Turkey.
Publication Type: Academic Journal
Source(s): Canadian Journal of Infectious Diseases & Medical Microbiology. 10/15/2022, Vol. 2022, p1-7. 7p.
Abstract: The diagnosis of new variants and monitoring their potential effects on diagnosis, therapeutics, and vaccines by genomic sequencing is essential to manage global public crises. In the current study, spike-genome next-generation sequencing was generated...
Antibodies from former COVID patients neutralise Delta, Omicron.
Publication Type: Periodical
Source(s): Lab+Life Scientist. Oct/Nov2022, Vol. 33 Issue 4, p30-31. 2p.
Abstract: "In the current study, we proved that two other antibodies, TAU-1109 and TAU-2310, which bind the viral spike protein in a different area from the region where most of the antibodies were concentrated until now (and were therefore less effective in neu...
Boosting in the age of Omicron.
Publication Type: Academic Journal
Source(s): eLife. 4/17/2023, p1-2. 2p.